Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus

Rheumatol Int. 2010 May;30(7):965-8. doi: 10.1007/s00296-009-1008-2. Epub 2009 Jun 18.

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired, autoimmune peripheral neuropathy. Systemic lupus erythematosus (SLE) is a multisystemic, autoimmune disease that can affect the central nervous system in about 40% of patients, with prevalence and incidence unknown in the pediatric population due to lack of multicenter studies. We report the case of a 13-year-old Mexican boy, diagnosed with CIDP at the onset of SLE, beginning with progressive muscle weakness of lower and upper limbs, without affection of the central nervous system. The patient had positive ANA, antiDNAdc, antiBeta2glycoprotein, anti-cardiolipin, ANCA-C and X. He received intravenous immunoglobulin, cyclophosphamide, steroids, and azathioprine and showed clinical improvement. It is important to take into account the presence of peripheral neurological disorders in patients with pediatric SLE, considering CIDP as an uncommon presentation, making the diagnosis important for better treatment and evolution.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use
  • Biomarkers / analysis
  • Biomarkers / blood
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Muscle Weakness / etiology
  • Peripheral Nerves / immunology
  • Peripheral Nerves / physiopathology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / blood
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / immunology*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / physiopathology*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Immunosuppressive Agents